149 related articles for article (PubMed ID: 28712490)
1. Pneumococcal vaccination for splenectomized patients with thalassemia major in Indonesia.
Sari TT; Akib AAP; Gatot D; Roswita Harahap A; Bardosono S; Hadinegoro SRS
Vaccine; 2017 Aug; 35(35 Pt B):4583-4586. PubMed ID: 28712490
[TBL] [Abstract][Full Text] [Related]
2. The effect of 23-valent pneumococcal polysaccharide vaccine on immunological priming induced by 7-valent conjugate vaccine in asplenic subjects with beta-thalassemia.
Orthopoulos GV; Theodoridou MC; Ladis VA; Tsousis DK; Spoulou VI
Vaccine; 2009 Jan; 27(3):350-4. PubMed ID: 19010369
[TBL] [Abstract][Full Text] [Related]
3. The total IgM, IgA and IgG antibody responses to pneumococcal polysaccharide vaccination (Pneumovax®23) in a healthy adult population and patients diagnosed with primary immunodeficiencies.
Parker AR; Park MA; Harding S; Abraham RS
Vaccine; 2019 Feb; 37(10):1350-1355. PubMed ID: 30737041
[TBL] [Abstract][Full Text] [Related]
4. Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.
Schaballie H; Wuyts G; Dillaerts D; Frans G; Moens L; Proesmans M; Vermeulen F; De Boeck K; Meyts I; Bossuyt X
Clin Exp Immunol; 2016 Aug; 185(2):180-9. PubMed ID: 26939935
[TBL] [Abstract][Full Text] [Related]
5. Serum antibody responses to vaccination with 23-valent pneumococcal vaccine in splenectomized patients.
Reinert RR; Kaufhold A; Kühnemund O; Lütticken R
Zentralbl Bakteriol; 1994 Nov; 281(4):481-90. PubMed ID: 7727895
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific B-cell response to 13-valent pneumococcal conjugate vaccine in asplenic individuals with β-thalassemia previously immunized with 23-valent pneumococcal polysaccharide vaccine.
Papadatou I; Piperi C; Alexandraki K; Kattamis A; Theodoridou M; Spoulou V
Clin Infect Dis; 2014 Sep; 59(6):862-5. PubMed ID: 24879786
[TBL] [Abstract][Full Text] [Related]
7. Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults.
McFetridge R; Meulen AS; Folkerth SD; Hoekstra JA; Dallas M; Hoover PA; Marchese RD; Zacholski DM; Watson WJ; Stek JE; Hartzel JS; Musey LK
Vaccine; 2015 Jun; 33(24):2793-9. PubMed ID: 25913828
[TBL] [Abstract][Full Text] [Related]
8. Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine.
Musher DM; Ceasar H; Kojic EM; Musher BL; Gathe JC; Romero-Steiner S; White AC
J Infect Dis; 2005 Apr; 191(7):1063-7. PubMed ID: 15747240
[TBL] [Abstract][Full Text] [Related]
9. Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: A randomised controlled trial.
Tashani M; Alfelali M; Barasheed O; Alqahtani AS; Heron L; Wong M; Rashid H; Booy R
Vaccine; 2016 Nov; 34(48):5929-5937. PubMed ID: 27780630
[TBL] [Abstract][Full Text] [Related]
10. Response to pneumococcal polysaccharide vaccine in children with asthma, and children with recurrent respiratory infections, and healthy children.
Quezada A; Maggi L; Norambuena X; Inostroza J; Quevedo F
Allergol Immunopathol (Madr); 2016; 44(4):376-81. PubMed ID: 27255476
[TBL] [Abstract][Full Text] [Related]
11. IgG subclass antibody responses to pneumococcal polysaccharide vaccine in splenectomized, otherwise normal, individuals.
Aaberge IS; Michaelsen TE; Heier HE
Scand J Immunol; 1990 Jun; 31(6):711-6. PubMed ID: 2356437
[TBL] [Abstract][Full Text] [Related]
12. [Factors Influencing Pneumococcal Vaccination-Induced Total IgG, IgG2, and IgA Levels in Vaccinated Splenectomized Patients].
Gazi U; Derici MK; Karasartova D; Güreser AS; Şahiner İT; Dolapçı M; Taylan Özkan A
Mikrobiyol Bul; 2022 Jan; 56(1):103-113. PubMed ID: 35088964
[TBL] [Abstract][Full Text] [Related]
13. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
[TBL] [Abstract][Full Text] [Related]
14. IgG and IgM antibody responses to pneumococcal vaccination in splenectomized children and in children who had non-operative management of splenic rupture.
Kalin M; Linné T; Eriksson M; Lännergren K; Tordal P; Jakobsson B; Lundmark KM
Acta Paediatr Scand; 1986 May; 75(3):452-6. PubMed ID: 3728005
[TBL] [Abstract][Full Text] [Related]
15. IgM and IgG response to pneumococcal polysaccharide vaccine in normal individuals and individuals splenectomized due to trauma.
Aaberge IS; Heier HE; Hem E; Giercksky KE; Groeng EC
Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):11-6. PubMed ID: 6711306
[TBL] [Abstract][Full Text] [Related]
16. Long-term effect of pneumococcal polysaccharide vaccination on serum IgM and IgG antibody levels in individuals splenectomized for trauma.
Aaberge IS; Heier HE
Acta Pathol Microbiol Immunol Scand C; 1984 Dec; 92(6):363-9. PubMed ID: 6524388
[TBL] [Abstract][Full Text] [Related]
17. Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: tailoring better vaccination strategies.
Rosado MM; Gesualdo F; Marcellini V; Di Sabatino A; Corazza GR; Smacchia MP; Nobili B; Baronci C; Russo L; Rossi F; Vito RD; Nicolosi L; Inserra A; Locatelli F; Tozzi AE; Carsetti R
Eur J Immunol; 2013 Oct; 43(10):2659-70. PubMed ID: 23813052
[TBL] [Abstract][Full Text] [Related]
18. Improved antibody responses to delayed pneumococcal vaccination in splenectomized rats.
Werner AM; Solis MM; Vogel R; Southerland SS; Ashley AV; Floyd JC; Brown C; Ashley DW
Am Surg; 1999 Sep; 65(9):844-7; discussion 847-8. PubMed ID: 10484087
[TBL] [Abstract][Full Text] [Related]
19. Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases.
Cherif H; Landgren O; Konradsen HB; Kalin M; Björkholm M
Vaccine; 2006 Jan; 24(1):75-81. PubMed ID: 16107293
[TBL] [Abstract][Full Text] [Related]
20. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity.
Uddin S; Borrow R; Haeney MR; Moran A; Warrington R; Balmer P; Arkwright PD
Vaccine; 2006 Jul; 24(27-28):5637-44. PubMed ID: 16730399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]